These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3128144)

  • 1. Vasodilator therapy in vasoconstrictor-induced pulmonary hypertension in sheep.
    Prielipp RC; Rosenthal MH; Pearl RG
    Anesthesiology; 1988 Apr; 68(4):552-8. PubMed ID: 3128144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in vasoconstrictor pulmonary hypertension in sheep.
    Prielipp RC; Rosenthal MH; Pearl RG
    Anesth Analg; 1988 Aug; 67(8):722-9. PubMed ID: 3293483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasodilator therapy in microembolic porcine pulmonary hypertension.
    McLean RF; Prielipp RC; Rosenthal MH; Pearl RG
    Anesth Analg; 1990 Jul; 71(1):35-41. PubMed ID: 2114065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prostaglandin E1 and hydralazine on the longitudinal distribution of pulmonary vascular resistance during vasoconstrictor pulmonary hypertension in sheep.
    Pearl RG; Siegel LC
    Anesthesiology; 1992 Jan; 76(1):106-12. PubMed ID: 1729914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diethylamine/nitric oxide (NO) adduct, an NO donor, produces potent pulmonary and systemic vasodilation in intact newborn lambs.
    Vanderford PA; Wong J; Chang R; Keefer LK; Soifer SJ; Fineman JR
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):113-9. PubMed ID: 7511722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled nitric oxide potentiates actions of adenosine but not of sodium nitroprusside in experimental pulmonary hypertension.
    Patterson KW; Deb B; Kavanagh BP; Pearl RG
    Pharmacology; 1999 May; 58(5):246-51. PubMed ID: 10087465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of beraprost, a stable analogue of prostacyclin, with PGE(1), nitroglycerin and nifedipine on canine model of vasoconstrictive pulmonary hypertension.
    Tamura M; Kurumatani H; Matsushita T
    Prostaglandins Leukot Essent Fatty Acids; 2001 Mar; 64(3):197-202. PubMed ID: 11334556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension.
    Walmrath D; Schermuly R; Pilch J; Grimminger F; Seeger W
    Eur Respir J; 1997 May; 10(5):1084-92. PubMed ID: 9163651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial ischemia during vasodilator therapy in a canine model of pulmonary hypertension and coronary insufficiency.
    Priebe HJ
    Anesthesiology; 1992 May; 76(5):781-91. PubMed ID: 1575347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide inhalation: effects on the ovine neonatal pulmonary and systemic circulations.
    DeMarco V; Skimming JW; Ellis TM; Cassin S
    Reprod Fertil Dev; 1996; 8(3):431-8. PubMed ID: 8795107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of diltiazem during vasoconstrictor pulmonary hypertension in sheep.
    Pearl RG; Finn JC
    Anesth Analg; 1990 Nov; 71(5):493-7. PubMed ID: 2221409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary vasodilator responses to nicardipine: comparison with other vasodilators.
    Matot I; Neely CF
    Crit Care Med; 1995 Nov; 23(11):1851-7. PubMed ID: 7587261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of vasoactive drugs on thromboxane A2 mimetic-induced pulmonary hypertension in newborn lambs.
    Crowley MR; Fineman JR; Soifer SJ
    Pediatr Res; 1991 Feb; 29(2):167-72. PubMed ID: 2014153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of inhalation of nebulized nitroglycerin on dogs with experimental pulmonary hypertension induced by U46619.
    Gong F; Shiraishi H; Momoi MY
    Chin Med J (Engl); 2000 May; 113(5):475-6. PubMed ID: 11776110
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhalation of nebulized nitroglycerin in dogs with experimental pulmonary hypertension induced by U46619.
    Gong F; Shiraishi H; Kikuchi Y; Hoshina M; Ichihashi K; Sato Y; Momoi MY
    Pediatr Int; 2000 Jun; 42(3):255-8. PubMed ID: 10881581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotriene antagonists attenuate thromboxane-inducible pulmonary hypertension.
    Soifer SJ; Schreiber MD; Heymann MA
    Pediatr Res; 1989 Aug; 26(2):83-7. PubMed ID: 2505220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of inhaled prostanoids in experimental pulmonary hypertension.
    Kleen M; Habler O; Hofstetter C; Pusch R; Mueller M; Welte M; Zwissler B
    Crit Care Med; 1998 Jun; 26(6):1103-9. PubMed ID: 9635662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E1 as a screening vasodilator in primary pulmonary hypertension.
    Halpern SM; Shah PK; Lehrman S; Goldberg HS; Jasper AC; Koerner SK
    Chest; 1987 Oct; 92(4):686-91. PubMed ID: 3652754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aerosolized milrinone during drug-induced pulmonary hypertension in lambs.
    Gelvez J; Fakioglu H; Olarte JL; Soliz A; Totapally BR; Torbati D
    Pharmacol Res; 2004 Jul; 50(1):87-91. PubMed ID: 15082033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of vasodilator therapy in canine model of acute pulmonary hypertension.
    Priebe HJ
    Am J Physiol; 1988 Nov; 255(5 Pt 2):H1232-9. PubMed ID: 3142278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.